A Phase II Study of RAD001 (Everolimus) and Pasireotide (SOM230)) in Patients with Advanced Uveal Melanoma
[Protocol 10-123] |
Carvajal, Richard |
|
A Phase II Study of Quizartinib in Patients with FLT3-ITD-Positive Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-106] |
Tallman, Martin |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase II Study of Pomalidomide plus Autologous Stem Cell Transplantation versus Pomalidomide/Dexamethasone in Patients with Multiple Myeloma
[Protocol 12-138] |
Giralt, Sergio |
|
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011] |
Ilson, David |
|
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS
[Protocol 08-008] |
Castro-Malaspina, Hugo |
- Blood & Marrow Stem Cell Transplantation
- Sibling and Unrelated Volunteer
- Blood and Marrow Transplantation
- Hematology
- Leukemia
- Acute Myelogenous Leukemia
|
A Phase II Study of PD0332991 in Patients with Advanced or Metastatic Liposarcoma
[Protocol 10-094] |
Dickson, Mark |
|
A Phase II Study of Partial Breast Irradiation for Select Patients with Early Invasive or Noninvasive Breast Cancer
[Protocol 10-114] |
Powell, Simon |
|
A Phase II Study of Palifermin with or without Leuprolide After T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-077] |
Goldberg, Jenna |
- Blood & Marrow Stem Cell Transplantation
- Hematology
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic Myelocytic Leukemia
- Lymphoma
|
A Phase II Study of Paclitaxel, Trastuzumab, and Pertuzumab for the Treatment of Metastatic HER2-Positive Breast Cancer
[Protocol 10-142] |
Dang, Chau |
|
A Phase II Study of New Treatment Approaches for High-Risk Renal Tumors
[Protocol 12-026] |
Kobos, Rachel |
|
A Phase II Study of Neoadjuvant Pemetrexed Plus Cisplatin for Patients with Resectable Non-Squamous Non-Small Cell Lung Cancer with "Switch Chemotherapy Alternative" in Non-Responders (NEOSCAN)
[Protocol 11-106] |
Chaft, Jamie |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer
[Protocol 12-071] |
Bajorin, Dean |
|
A Phase II Study of MLN8237 in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
[Protocol 12-096] |
Horwitz, Steven |
|
A Phase II Study of MLN8237 in Patients with Recurrent or Persistent Uterine Leiomyosarcoma
[Protocol 12-164] |
Hyman, David |
- Endometrial and other Uterine Cancers
- Leiomyosarcoma
- Uterine Cancer
- Leiomyosarcoma
- Sarcomas
- Leiomyosarcoma
- Soft Tissue Sarcoma
|
A Phase II Study of MLN8237 in Patients with Advanced Prostate Cancer
[Protocol 13-042] |
Danila, Daniel |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194] |
Dickson, Mark |
|
A Phase II Study of MLN8237 (Alisertib) with Paclitaxel versus Paclitaxel Alone in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-100] |
Tew, William |
|
A Phase II Study of MK-2206 in Patients with Recurrent or Advanced Endometrial Cancer Stratified by PIK3CA Mutation Status
[Protocol 11-071] |
Makker, Vicky |
- Endometrial and other Uterine Cancers
|
A Phase II Study of MK-2206 in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
[Protocol 11-193] |
Ho, Alan |
|
A Phase II Study of mFOLFOX6 with Bevacizumab or Tivozanib in Patients with Metastatic Colorectal Cancer
[Protocol 12-066] |
Cercek, Andrea |
|
